A randomized phase II trial of nab‐paclitaxel and gemcitabine with tarextumab or placebo in patients with untreated metastatic pancreatic cancer

Zishuo Ian Hu, Johanna C. Bendell, Andrea Bullock, Noelle K. LoConte, Hassan Hatoum, Paul Ritch, Hugo Hool, Joseph W. Leach, James Sanchez, Davendra P. S. Sohal, John Strickler, Ravindranath Patel, Andrea Wang‐Gillam, Irfan Firdaus, Kenneth H. Yu, Ann M. Kapoun, Eric Holmgren, Lei Zhou, Jakob Dupont, Vincent Picozzi, Vaibhav Sahai, Eileen M. O'Reilly

Open source

DOI: 10.1002/cam4.2425
Published: 2019-07-26
Container: Cancer Medicine
Publisher: Wiley
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/cam4.2425,
  title = {A randomized phase II trial of nab‐paclitaxel and gemcitabine with tarextumab or placebo in patients with untreated metastatic pancreatic cancer},
  author = {Zishuo Ian Hu and Johanna C. Bendell and Andrea Bullock and Noelle K. LoConte and Hassan Hatoum and Paul Ritch and Hugo Hool and Joseph W. Leach and James Sanchez and Davendra P. S. Sohal and John Strickler and Ravindranath Patel and Andrea Wang‐Gillam and Irfan Firdaus and Kenneth H. Yu and Ann M. Kapoun and Eric Holmgren and Lei Zhou and Jakob Dupont and Vincent Picozzi and Vaibhav Sahai and Eileen M. O'Reilly},
  year = {2019},
  journal = {Cancer Medicine},
  doi = {10.1002/cam4.2425},
  url = {https://doi.org/10.1002/cam4.2425}
}

RIS

TY  - JOUR
TI  - A randomized phase II trial of nab‐paclitaxel and gemcitabine with tarextumab or placebo in patients with untreated metastatic pancreatic cancer
AU  - Zishuo Ian Hu
AU  - Johanna C. Bendell
AU  - Andrea Bullock
AU  - Noelle K. LoConte
AU  - Hassan Hatoum
AU  - Paul Ritch
AU  - Hugo Hool
AU  - Joseph W. Leach
AU  - James Sanchez
AU  - Davendra P. S. Sohal
AU  - John Strickler
AU  - Ravindranath Patel
AU  - Andrea Wang‐Gillam
AU  - Irfan Firdaus
AU  - Kenneth H. Yu
AU  - Ann M. Kapoun
AU  - Eric Holmgren
AU  - Lei Zhou
AU  - Jakob Dupont
AU  - Vincent Picozzi
AU  - Vaibhav Sahai
AU  - Eileen M. O'Reilly
PY  - 2019
JO  - Cancer Medicine
DO  - 10.1002/cam4.2425
UR  - https://doi.org/10.1002/cam4.2425
ER  -

APA

Hu, Z. I., Bendell, J. C., Bullock, A., LoConte, N. K., Hatoum, H., Ritch, P., Hool, H., Leach, J. W., Sanchez, J., Sohal, D. P. S., Strickler, J., Patel, R., Wang‐Gillam, A., Firdaus, I., Yu, K. H., Kapoun, A. M., Holmgren, E., Zhou, L., Dupont, J., Picozzi, V., Sahai, V., & O'Reilly, E. M. (2019). A randomized phase II trial of nab‐paclitaxel and gemcitabine with tarextumab or placebo in patients with untreated metastatic pancreatic cancer. Cancer Medicine. https://doi.org/10.1002/cam4.2425

Source records

crossref · retrieved 2026-09-26T05:28:57.627Z